EhmetDX

EhmetDX

Delivering advanced breast irradiation with precision and protection, paving the way for faster and more sophisticated treatment techniques.

Founded 2015 11-50 employees Grant Total: $510.00K Biotechnology, Health Care +2

EhmetDX is a biotechnology startup that focuses on delivering advanced breast irradiation with precision and protection, thereby paving the way for faster and more sophisticated treatment techniques. Founded in 2015, the company specializes in bringing forward the latest breakthroughs in medical device technology to fulfill specific needs in the healthcare sector. EhmetDX's proprietary technology enables practitioners to administer either whole or partial breast irradiation while minimizing risk to vital structures like the lungs, heart, and skin, and reducing the overall radiation dose to the patient. This innovative approach empowers clinicians to employ advanced methods such as accelerated radiation treatment, thereby shortening procedure times and facilitating advanced techniques like stereotactic radiation therapy. The venture recently secured a $510.00K grant investment in December 2018, with the investment coming from the U.S. Food and Drug Administration. EhmetDX operates within the industries of Biotechnology, Health Care, Health and Wellness, and Medical Devices, showcasing a strong potential for growth and impact within the medical technology sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$510.00K	1	U.S. Food and Drug Administration	14 Dec 2018
Seed Round	Undisclosed	1	Third Seven Capital	01 Feb 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$510.00K

U.S. Food and Drug Administration

14 Dec 2018

Seed Round

Undisclosed

Third Seven Capital

01 Feb 2017

FAQ About EhmetDX

Delivering advanced breast irradiation with precision and protection, paving the way for faster and more sophisticated treatment techniques.

EhmetDX was founded in 2015.

EhmetDX operates in Biotechnology, Health Care, Health and Wellness and Medical Devices. Its work centres on Radiation Therapy, Proton Therapy, Radiotherapy and Breast Cancer.

EhmetDX has approximately 11-50 employees.

EhmetDX has completed 2 funding rounds, raising a total of $510.00K. The latest funding stage is Grant.

Top alternatives and competitors to EhmetDX include Cianna Medical, Mevion Medical Systems, ALCELI, UNIVERSAL RADIOTHERAPY R&D, 株式会社ビードットメディカル. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

EhmetDX and Cianna Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About EhmetDX

Funding Rounds & Investors (2)

EhmetDX Alternatives & Competitors

FAQ About EhmetDX